Login / Signup

Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT).

Mark GilchristConor JamiesonFelicity DrummondTim HillsR Andrew SeatonMark Santillo
Published in: JAC-antimicrobial resistance (2023)
Keyphrases
  • gram negative
  • electronic health record
  • staphylococcus aureus
  • low dose
  • oxidative stress
  • multidrug resistant
  • big data
  • bone marrow
  • data analysis
  • mesenchymal stem cells
  • smoking cessation
  • replacement therapy